Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $20.42B | Healthcare | Pharmaceuticals | United States | NYSE |
| 2 | $13.99B | Healthcare | Biotechnology | United States | Nasdaq |
| 3 | $11.33B | Healthcare | Pharmaceutical Retailers | United States | NYSE |
| 4 | $8.95B | Healthcare | Pharmaceuticals | United States | NYSE |
| 5 | $6.85B | Healthcare | Pharmaceuticals | United States | NYSE |
| 6 | $6.57B | Healthcare | Pharmaceuticals | United States | NYSE |
| 7 | $6.14B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 8 | $5.10B | Healthcare | Pharmaceuticals | United States | NYSE |
| 9 | $5.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 10 | $4.35B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 11 | $4.06B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 12 | $3.98B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 13 | $3.39B | Healthcare | Medical Devices | United States | NYSE |
| 14 | $3.18B | Healthcare | Biotechnology | United States | Nasdaq |
| 15 | $2.96B | Healthcare | Medical Devices | United States | NYSE |
| 16 | $2.91B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 17 | $2.76B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 18 | $2.46B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 19 | $2.33B | Healthcare | Medical Devices | United States | Nasdaq |
| 20 | $2.31B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 21 | $2.17B | Healthcare | Healthcare Providers | United States | NYSE |
| 22 | $2.12B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 23 | $2.08B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 24 | $1.91B | Healthcare | Diagnostics & Research | United States | NYSE |
| 25 | $1.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 26 | $1.72B | Healthcare | Biotechnology | United States | Nasdaq |
| 27 | $1.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 28 | $1.65B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 29 | $1.62B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 30 | $1.52B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 31 | $1.48B | Healthcare | Pharmaceuticals | United States | NYSE |
| 32 | $1.47B | Healthcare | Medical Devices | United States | NYSE |
| 33 | $1.32B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 34 | $1.28B | Healthcare | Biotechnology | United States | Nasdaq |
| 35 | $1.25B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 36 | $1.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 37 | $1.16B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 38 | $1.13B | Healthcare | Pharmaceuticals | United States | NYSE |
| 39 | $1.13B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 40 | $1.10B | Healthcare | Medical Devices | United States | Nasdaq |
| 41 | $1.10B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 42 | $1.09B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 43 | $1.09B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 44 | $1.05B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 45 | $1.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 46 | $1.04B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 47 | $1.01B | Healthcare | Healthcare Providers | United States | NYSE |
| 48 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 49 | $976.00M | Healthcare | Pharmaceuticals | United States | NYSE |
| 50 | $886.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 51 | $874.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 52 | $815.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 53 | $811.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 54 | $797.80M | Healthcare | Biotechnology | United States | Nasdaq |
| 55 | $774.35M | Healthcare | Healthcare Providers | United States | NYSE |
| 56 | $745.23M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 57 | $726.27M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 58 | $708.00M | Healthcare | Medical Devices | United States | NYSE |
| 59 | $690.91M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 60 | $677.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 61 | $676.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 62 | $668.96M | Healthcare | Healthcare Providers | United States | NYSE |
| 63 | $626.00M | Healthcare | Healthcare Providers | United States | NYSE |
| 64 | $609.81M | Healthcare | Healthcare Providers | United States | NYSE |
| 65 | $606.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 66 | $598.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 67 | $593.30M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 68 | $570.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 69 | $550.38M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 70 | $549.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 71 | $548.63M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 72 | $545.68M | Healthcare | Biotechnology | United States | Nasdaq |
| 73 | $544.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 74 | $539.00M | Healthcare | Medical Devices | United States | NYSE |
| 75 | $539.00M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 76 | $534.90M | Healthcare | Medical Devices | United States | Nasdaq |
| 77 | $530.00M | Healthcare | Pharmaceuticals | United States | NYSE |
| 78 | $517.00M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 79 | $516.62M | Healthcare | Medical Devices | United States | Nasdaq |
| 80 | $511.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 81 | $507.75M | Healthcare | Medical Devices | United States | NYSE |
| 82 | $502.69M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 83 | $502.51M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 84 | $495.45M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 85 | $482.57M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 86 | $482.30M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 87 | $479.00M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 88 | $474.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 89 | $455.41M | Healthcare | Biotechnology | United States | Nasdaq |
| 90 | $454.00M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 91 | $448.70M | Healthcare | Medical Devices | United States | Nasdaq |
| 92 | $437.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 93 | $435.80M | Healthcare | Medical Devices | United States | NYSE |
| 94 | $427.74M | Healthcare | Biotechnology | United States | Nasdaq |
| 95 | $424.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 96 | $420.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 97 | $419.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 98 | $413.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 99 | $412.20M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 100 | $410.00M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
U.S.-exchange common stocks; ADRs and funds excluded. 691 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.